The World Health Organization has identified widespread resistance to older and cheaper antibiotics in gonorrhea strains around the world, suggesting the infection is becoming more difficult — and sometimes impossible — to treat.
For the study, researchers pitted closthioamide — a new class of antibiotics yet to be tested in humans or animals — against 149 samples of N. gonorrhoeae extracted from patients with infections in the throat, urethra, cervix and rectum.
The antibiotics successfully inhibited the bacteria in all but three of the samples.
“The imminent threat of untreatable antibiotic-resistant infectious diseases, including gonorrhea, is a global problem, for which we urgently need new antibiotics,” said John Heap, PhD, a lecturer on synthetic biology at Imperial College London and one of the study’s authors. “This new finding might help us take the lead in the arms race against antimicrobial resistance.”
More articles on infection control:
Pro-vaccine messages can backfire, study finds
Top 10 infection control stories, July 31-Aug. 4
CDC quarantines surgical gowns at center of ’60 Minutes’ investigation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.